相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Discovery of (2S,4R)-1-(2-Aminoacetyl)-4-benzamidopyrrolidine-2-carboxylic Acid Hydrochloride (GAP-134)13, an Orally Active Small Molecule Gap-Junction Modifier for the Treatment of Atrial Fibrillation
John A. Butera et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Maintenance of intercellular coupling by the antiarrhythmic peptide rotigaptide suppresses arrhythmogenic discordant alternans
Anne Louise Kjolbye et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Simultaneous right atrioventricular pacing: A novel model to study atrial remodeling and fibrillation in the setting of heart failure
Gabriel Laurent et al.
JOURNAL OF CARDIAC FAILURE (2008)
Long chain n-3 polyunsaturated fatty acids reduce atrial vulnerability in a novel canine pacing model
Gabriel Laurent et al.
CARDIOVASCULAR RESEARCH (2008)
Pharmacological modulation of gap junction function with the novel compound rotigaptide: A promising new principle for prevention of arrhythmias
Anne Louise Kjolbye et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2007)
Effects of rotigaptide, a gap junction modifier, on defibrillation energy and resuscitation from cardiac arrest in rabbits
Jing-quan Zhong et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2007)
Model-dependent effects of the gap junction conduction-enhancing antiarrhythmic peptide rotigaptide (ZP123) on experimental atrial fibrillation in dogs
Akiko Shiroshita-Takeshita et al.
CIRCULATION (2007)
Arrhythmogenic ion-channel remodeling in the heart: Heart failure, myocardial infarction, and atrial fibrillation
Stanley Nattel et al.
PHYSIOLOGICAL REVIEWS (2007)
Structural atrial remodeling alters the substrate and spatiotemporal organization of atrial fibrillation: a comparison in canine models of structural and electrical atrial remodeling
Thomas H. Everett et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Effects of the gap junction modifier rotigaptide (ZP123) on atrial conduction and vulnerability to atrial fibrillation
Jose M. Guerra et al.
CIRCULATION (2006)
Rotigaptide (ZP123) improves atrial conduction slowing in chronic volume overload-induced dilated atria
Ketil Haugan et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2006)
Rotigaptide (ZP123) prevents spontaneous ventricular arrhythmias and reduces infarct size during myocardial ischemia/reperfusion injury in open-chest dogs
JK Hennan et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Critical mass hypothesis revisited: role of dynamical wave stability in spontaneous termination of cardiac fibrillation
ZL Qu
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
The effects of connexin phosphorylation on gap junctional communication
PD Lampe et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2004)
Pharmacological modulation of cardiac gap junctions to enhance cardiac conduction - Evidence supporting a novel target for antiarrhythmic therapy
BC Eloff et al.
CIRCULATION (2003)
Pharmacological characterization of the new stable antiarrhythmic peptide analog Ac-D-Tyr-D-Pro-D-Hyp-Gly-D-Ala-Gly-NH2 (ZP123):: In vivo and in vitro studies
AL Kjolbye et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
ZP123 increases gap junctional conductance and prevents Reentrant ventricular tachycardia during myocardial ischemia in open chest dogs
DZ Xing et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2003)
Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: Comparative efficacy and results of trials
GV Naccarelli et al.
AMERICAN JOURNAL OF CARDIOLOGY (2003)
New ideas about atrial fibrillation 50 years on
S Nattel
NATURE (2002)
Effects of chronic atrial fibrillation on gap junction distribution in human and rat atria
L Polontchouk et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2001)